← All stocks

Replimune Group, Inc.

REPL No buying or selling
CIK 0001737953 #2319 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

7 insiders · 0 transactions
14.4×

Sushil Patel holds 14.4 times base salary in stock. $10.11M of shares against $700.00K in salary for 2026.

Salary from the company's own proxy. The shares are what Sushil Patel last reported holding, valued at $14.28, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Astley-Sparke Philip
Director
1,362,414
$19.46M
−5.2%
Patel Sushil
Chief Executive Officer
708,151
$10.11M
+234.0%
Xynos Konstantinos
Chief Medical Officer
224,215
$3.20M
+91.4%
Hill Emily Luisa
Chief Financial Officer
215,852
$3.08M
+113.6%
Sarchi Christopher
Chief Commercial Officer
180,962
$2.58M
+96.2%
Schwendenman Andrew
Chief Accounting Officer
99,425
$1.42M
−44.2%
Dhingra Kapil
Director
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 25 Jul 2018